OPKO HEALTH, INC. 8-K

What Happened
OPKO Health, Inc. announced operating and financial highlights for the quarter ended June 30, 2026 in a press release dated July 27, 2026. The company said it will host a conference call to provide a business update, discuss its second-quarter 2026 financial and operating results, and present financial guidance. A copy of the press release is attached to the 8-K as Exhibit 99.1.

Key Details

• Filing date: July 27, 2026; quarter covered: quarter ended June 30, 2026.
• Press release attached as Exhibit 99.1 to the Form 8-K.
• Company will host a conference call to review quarterly results and provide financial guidance (access details are in the press release).
• Form 8-K signed by Adam Logal, Senior VP and Chief Financial Officer, on July 27, 2026.
• The press release information is identified as not being “filed” under Section 18 of the Exchange Act and not incorporated by reference in other filings unless expressly stated.

Why It Matters
This filing signals that OPKO is reporting its quarterly earnings-related information and will give forward-looking guidance that could affect investor expectations for revenue, earnings, and near-term strategy. Retail investors should review the attached press release and consider listening to the conference call for specific revenue, profit, and guidance figures that may influence the stock’s outlook.